EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers
Publication date
2020-12
Authors
Bakker, Daphne S
Ariëns, Lieneke F.M.
Giovannone, Barbara
Hijnen, Dirk Jan
Delemarre, Eveline M
Knol, Edward F.
Nierkens, Stefan
de Bruin-Weller, Marjolein
Thijs, Judith L.
Drylewicz, Julia
Editors
Advisors
Supervisors
Document Type
Comment
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
Keywords
atopic dermatitis, biologics, biomarkers, Immunology and Allergy, Immunology, Journal Article
Citation
Bakker, D S, Ariens, L F M, Giovannone, B, Hijnen, D, Delemarre, E M, Knol, E, Nierkens, S, de Bruin-Weller, M S, Thijs, J L & Drylewicz, J 2020, 'EASI p-EASI: Predicting disease severity in atopic dermatitis patients treated with dupilumab using a combination of serum biomarkers', Allergy, vol. 75, no. 12, pp. 3287-3289. https://doi.org/10.1111/all.14492